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Diabetes is both an endocrine and a metabolic disease affecting large numbers of individuals worldwide. The use of 
natural products such as herbs in the management of diseases dates back to the prehistoric era. Herbal therapy presents a less 
adverse side effect when compared with the synthetic orthodox counterpart. The phytochemical components of medicinal 
plants have been credited for the efficacy of herbal formulations. The aim of this study is to review some common anti-
diabetic plants which have been tested experimentally using recent diabetes marker parameters and to highlight the bioactive 
anti-diabetic principles isolated from their phytochemicals. In addition, anti-diabetic compounds isolated in the process of 
research in our laboratory have been cited in the review. Such keywords like anti-diabetic medicinal plants, mechanism of 
actions, phytochemicals, alloxan, streptozotocin, glycosylated haemoglobin, were used on different search engines to 
generate secondary data used in this review. Data obtained indicated that various phytochemical components of anti-diabetic 
herbs such as the flavonoids, saponins, tannins, alkaloids, glycosides, terpenes, were responsible for the said anti-diabetic 
activities of the plants. The data equally revealed that these phytochemicals acted in diverse mechanisms to bring about their 
activities. From the data obtained, it was concluded that phytochemicals from anti-diabetic medicinal plants/herbs are 
pivotal in the production of marketable novel and efficacious anti-diabetic drug in future. 
Keywords: Anti-diabetic medicinal plants, Alloxan, Diabetes markers, Mechanism of action, Phytochemicals, 
Streptozotocin. 
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Introduction 
Diabetes mellitus is an endocrine disease resulting 
from insulin deficiency, insulin inaction or both1. It is 
characterized by polydipsia, polyurea, ketonemia and 
ketonuria2. These and other clinical signs and 
symptoms of D. mellitus if left unattended to, will 
precipitate diabetic complications which on their own 
have been fingered as the most frequent causes of 
morbidity and mortality in diabetics3. 
Hyperglycemia has been implicated in the 
development of secondary complications in D. mellitus. 
Aldose reductase, a very important enzyme in Polyol 
pathway is therefore activated in the condition of  
D. mellitus4. 
Diabetes, “Diab” from Greek word meaning “to 
pass through” and “mellitus” from Latin word 
meaning “sweetened with honey” is a disease 
associated with glycosuria (presence of sugar in 
urine)5. World Health Organization predicts that by 
the year 2025, about 300 million or more people are 
likely going to have diabetes with the United States, 
China and India leading6. D. mellitus is also one of 
the diseases of animals such as dogs and cats. 
Traditionally, D. mellitus is classified into two-type 
1 D. mellitus (insulin dependent D. mellitus) and type 
2 D. mellitus (non-insulin dependent D. mellitus)7. 
The former is common in juveniles (thus referred to 
as juvenile diabetes and it is associated with the auto-
immune mediated destruction of pancreatic beta cells 
in which case the affected individual requires exogenous 
administration of insulin for its management)  
while the latter is predominant in adults (adult onset) 
and it is mainly associated with peripheral insulin 
resistance7,8. 
Management of D. mellitus employs modifications 
of diet, change of lifestyle, intake of oral hypoglycemic, 
administration of exogenous insulin and herbal 
remedies9. Synthetic drugs are fraught with adverse 
side effects10,11. Natural products such as plants and 
herbs have the capacity to reduce blood glucose 
values and ameliorate diabetes with reduced adverse 
side effects5. They achieve this owing to the presence 
of phytochemicals such as flavonoids, saponins, 
alkaloids, tannins, glycosides, terpenes etc8. 
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The aim of this review is to highlight the 
importance of natural products such as herbs in the 
management of D. mellitus owing to the presence of 
bioactive phytochemical components. The mechanisms 
by which these active principles of phytochemical 
origin bring about their effects are also discussed. 
 
Flavonoids 
Flavonoids are a group of plant metabolites  
that constitute a family of soluble polyphenolic 
compounds. They are made up of two benzene rings 
attached by a short three carbon chain12,15. Flavonoids 
that occur in nature are classified into six classes 
namely: anthocyanidins (e.g. cyanidin, delphinidin, 
malvidin, peonidin, petunidin etc), flavan-3-ols (e.g. 
catechin, epicatechin, gallocatechin etc), flavonols 
(isorhamnetin, kaempferol, myricetin, quercetin), 
flavones (e.g. apigenin, luteolin, baicalein, chrysin), 
flavanones (eriodictyol, hesperetin, naringenin) and 
isoflavones (daidzein, genistein, glycitein, biochanin 
A)12,13. The anti-diabetic properties of flavonoids are 
attributed partly to their antioxidant potentials and 
partly due to their ability to modulate some cell 
signalling. Dietary flavonoids occur in fruits, vegetables, 
beverages, chocolates, herbs and plants14,15. The 
following flavonoids isolated from plants have been 
shown to possess anti-diabetic properties. 
 
Diosmin 
Diosmin is a flavonoid that occurs in citrus plants 
naturally. Experimental evidencs have revealed its 
potent anti-diabetic activities mediated by decreases 
in the level of glycosylated haemoglobin, increases  
in the activities of glutathione peroxidases16,17, 
significant reductions in plasma glucose values, 
increases in hepatic hexokinases and glucose-6-
phosphate dehydrogenases18, increasing insulin levels 
and ameliorating oxidative stress as evidenced by 
assay of superoxide dismutase, catalase and glutathione 
peroxidase activities. It also increased the levels  
of vitamins C and E19. Diosmin is isolated from 
Scrophularia nodosa, an anti-diabetic plant. 
 
Fisetin 
This flavonoid brings about its anti-diabetic effect 
by inhibiting gluconeogenesis through inhibition of 
mitochondrial pyruvate transport and a decrease in the 
cytosolic NADH/NAD redox20. Decreasing of glycogen 
breakdown, plasma glucose levels, glycosylated 
haemoglobin, mRNA and protein expression levels  
of gluconeogenic genes like phosphoenol pyruvate 
carboxykinase and by increasing plasma insulin are 
among the mechanisms by which fisetin brings about 
its anti-diabetic actions21. Moreover, hypoglycaemic 
activities of fisetin flavonoids have been associated 
with significant decreases in nuclear factor kappa B 
(NF-kB) p65 unit, interleukin-1β (IL-1β)and serum 
nitric oxide (NO)21. Fisetin, produced by Cotinus 
coggygria Scop and also found ubiquitously in 
strawberry, apple, grape, onions and cucumber has 
been advocated for use in the prevention of 
diabetes22,23. 
 
Morin 
Morin-treated diabetic rats showed anti-diabetic 
activities by improvement of antioxidant agents, 
reduction of insulin resistance, decrease in oxidative 
stress parameters, normalization of lipids and 
lipoproteins and decreases in the levels of tumour 
necrosis factor alpha (TNFα)24. Experimental 
evidence also suggests that morin reduced 
inflammatory cytokines IL-1β and IL-6 in diabetic 
animals25. Recovery of hepatic insulin and leptin 
sensitivity, reduction in hyperlipidaemia and liver-
lipid accumulation have been fingered as mechanisms 
by which morin brings about its anti-diabetic 
actions26. Morin has been shown to reduce glucose-6-
phosphatase activities, increase hexokinase, and 
glucose-6-phosphate dehydrogenase activities and 
insulin levels27. Morin is contained in many medicinal 
herbs such as Prunus dulcis (Mill), Chlorophora 
tinctoria (L), Psidium guajava28,29. 
 
Eriodictyol 
Suppression of oxidative stress, up-regulation of 
mRNA expression of peroxisome proliferator-
activated receptor gamma (PPARγ) and adipocyte-
specific fatty acid-binding protein together with the 
protein levels of PPARγ2 in differentiated 3T3-L1 
adipocytes are key mechanisms involved in the anti-
diabetic activity of eriodictyol. It has also been 
implicated in the reduction of retinal TNFα, 
intercellular adhesion molecule-1 (ICAM-1), vascular 
endothelial growth factor (VEGF), endothelia nitric 
oxide synthase (eNOS) and lipid peroxides30,31. 
Lemon fruits contain eriodictyol in abundance32. 
 
Hesperidin 
This flavonoid is ubiquitous in plants of the genus 
citrus especially Citrus aurantium33,34. Like eridictyol, 
hesperidin exhibits anti-diabetic activity by down 
regulating the generation of free radicals and the 
release of pro-inflammatory cytokines35,37. Normalization 
of the lipids and adiponectin together with alterations 
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of the activities of glucose metabolizing enzymes 
decreases in the levels of thiobarbituric acid reactive 
substances (TBARS) and increases in the activities of 
lactate dehydrogenase (LDH) have been reported with 
hesperidin administration38,39. 
 
Naringenin 
Citrus fruits and tomatoes contain naringenin  
in abundance, which confers antioxidant properties  
to these fruits40. Cochlospermun also contains 
naringenin in large amount41. Naringenin inhibits  
α-glucosidase activities. It also inhibits glucose 
uptake in vitro and interferes with genes associated 
with lipid metabolism42,43. Activation of 5′AMP-
activated protein kinase (AMPK), enhancement of 
antioxidant activities, reduction of insulin resistance 
and improvement in hepatic function markers are also 
thought to be the mechanism of action of naringenin44-46. 
 
Apigenin 
This flavone flavonoid is ubiquitous in citrus, 
onions, vegetables, tea and nut47. Its mechanism of 
action is through the improvement of antioxidant 
parameters, enhancement of glucose transporter 4 
(GLUT4) translocation and beta cell preservation48,49. 
 
Baicalein 
Baicalein scavenges free radicals, induces insulin 
production, reduces glycosylated haemoglobin, 
suppresses the activation of NF-kB, decreases the 
expression of inducible nitric oxide synthase (iNOS) 
and transforming growth factor beta (TGF-β)50,51. 
Another major mechanism by which Baicalein 
operates is by up-regulation of AMPK44. This 
flavonoid is present in the roots of Scutellaria 
baicalensis and fruits of Oroxylum indicum52,53. 
 
Chrysin 
It is a major component of Oroxylum indicum. It 
has also been isolated from Passiflora caerulea, 
Pelargonium peltatum, Tilia tomentosa, bee pollen, 
honey, fruits and vegetables54-56. Treatment with 
chrysin has been associated with suppression of TGF-
β, fibronectin, and collagen-IV protein expression in 
the kidney. Serum levels of IL-1β and IL-6 were also 
reduced. With these observations, chrysin is thought 
to prevent nephropathy51. Chrysin administration also 
improves insulin levels and reduces lipid peroxidation57. 
 
Luteolin 
Luteolin is known to potentiate insulin action and 
increase transcriptional activation of PPARγ58. 
Luteolin also decreases circulating levels of 
inflammatory molecules, Monocyte Chemotactic 
Protein-1 (MCP-1), resistin and elevates adiponectin 
levels in obese mice59. It is also on record that luteolin 
improves insulin secretion60. Luteolin is found in 
abundance in carrots, peppers, cabbage, apple, 
vegetables and fruits61-63. 
 
Tangeretin 
Tangeretin administration decreased total 
cholesterol, leptin, resistin, IL6 and MCP-164. It is 
also in the literature that its administration 
significantly decreased glycosylated haemoglobin, 
improved insulin levels, enhanced glycolytic 
enzymes, controlled glucose metabolism in hepatic 
tissues and decreased an insulin-resistant factor, 
MCP-1 in 3T3-L1 adipocytes65. Rinds of citrus fruits 
contain tangeretin. 
 
Wogonin 
This is obtained from the root of Scutellaria 
baicalensis66. Wogonin interferes with insulin 
sensitivity and lipid metabolism through its effect on 
AMPK and PPARα67. 
 
Isorhamnetin 
It is an anti-diabetic principle isolated from 
Hippophae rhamnoides, Oenanthe javanica and 
Ginkgo biloba. Its administration reduces oxidative 
stress, inhibits sorbitol accumulation and interferes 
with lipid metabolism68-70. 
 
Kaempferol 
This flavonol is present in Ginkgo biloba, tea, 
grapefruits, edible berry and vegetables71-73. Its 
administration is associated with the inhibition of 
apoptosis, reduction of caspase-3 activity in beta cells, 
improvement of cAMP signalling and enhancement of 
insulin synthesis and secretion74. It is also associated 
with the enhancement of antioxidant production and 
reduction of IL-1β, TNFα, lipid peroxidation, nitrite 
and glycosylated haemoglobin75,76. 
 
Rutin  
Oranges, grapes, buckwheat, lemons, limes, berries 
and peaches contain rutin77,78. Rutin improves insulin 
secretion, restores glycogen content, decreases  
the level of oxidative stress, inhibits advanced 
glycation end products (AGEs) formation, decreases 
glycosylated haemoglobin and pro-inflammatory 
cytokines such as IL-6 and TNFα and restores liver 
antioxidant status79,80. 
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Quercetin 
It is a flavonol flavonoid present in onions, berries, 
apples, pepper and coriander81,82. Its anti-diabetic 
actions are exhibited by increases in anti-oxidant 
enzymes, decreases in lipid peroxidation, reduction  
in intestinal glucose absorption by inhibiting 
GLUT283,84. Quercetin blocks tyrosine kinase and also 
the recovery of cell proliferation85. 
 
Genistein 
This is an isoflavone flavonoid present in legumes. 
Sophora subprostrala and Genista tinctoria contain 
genistein86. Renal TBARS were reduced upon 
genistein administration. It also improves glucose 
tolerance and increases blood insulin level without 
affecting body weight87. 
 
Daidzein 
Daidzein, an isoflavone flavonoid is present in 
nuts, soybeans and fruits. Daidzein improves lipid and 
glucose metabolism, improves insulin sensitivity and 
enhances AMPK phosphorylation in muscles88-91. 
 
Cyanidin 
Cyanidin, an anthocyanin flavonoid exhibits its 
anti-diabetic actions by inhibiting α-glucosidase and 
pancreatic α-amylase92. It also prevents pancreatic 
apoptosis and improves antioxidant status93,94. 
 
Delphinidin 
This is anthocyanin present in berries, tomatoes, 
eggplant, vegetables, carrots, sweet potatoes, red 
cabbage and red onions. Its anti-diabetic activity is 
mediated through its antioxidant effects and 
reductions in albumin and haemoglobin glycations95. 
 
Pelargonidin 
It is present in blackberries, cranberries, ripe 
raspberries and blueberries96. Its administration 
relieves oxidative stress, nitrite levels and stimulates 
insulin secretion97,98. 
 
Saponins 
Saponins are major plant metabolites that naturally 
occur as surface-active glycosides99. They are 
composed of sugar moieties linked to a hydrophobic 
aglycone known as sapogenin which could also be a 
triterpenoid or a steroid100. Several anti-diabetic 
medicinal plants owe their activities to saponins. The 
anti-diabetic properties of Anabasis articulate are as a 
result of saponin present in it101. The saponin induces 
insulin production. Amelioration of oxidative  
stress and AGES formation effects of Astragalus 
membranaceous is attributed to its saponin102. 
Diosgenin, a saponin from Dioscorea rotundata is 
noted for increasing the activity of glucose-6-
phosphate103. Saponins from Enteda phaseoloides 
have the ability to elevate serum insulin levels, 
alleviate hyperglycemia and decrease lipid levels104. 
Administration of saponin from Garcinia kola to 
alloxan-induced diabetic rats reduced significantly, 
the plasma glucose levels consequent upon insulin 
release from the pancreas105. Helicteres isora saponin 
is known to reduce serum lipid, plasma glucose, 
expression of the fatty acid binding protein and 
glucose-6-phosphatase and at the same time increases 
GLUT 4106. Saponin from the fruit of Mormodica 
charantia has been reported to have anti-diabetic 
property. It does this by inhibiting disaccharidase 
activity107. Triterpene saponins isolated from this plant 
activated AMPK greater than that achieved by 
troglitazone108. 
Geinoside is a saponin isolated from Panax notoginseng 
and it is known to inhibit gluconeogenesis109. 
Platycodi radix produces platyconic acid, a saponin 
which is involved in insulin-stimulated glucose 
uptake in the 3T3-L1 adipocyte. The saponin is 
known to increase glycogen accumulation and 
decrease triacylglycerol storage in the liver. It also 
enhanced the expression of adiponectin and PPARγ in 
adipose tissues, improve insulin signalling and 
increases GLUT 4110. 
The saponin-rich fraction of Polygonatum 
adoratum alleviated signs of diabetes and enhanced 
glucose uptake. Increases in superoxide dismutase 
activity and decreases in malondialdehyde levels were 
observed upon the administration of the saponin111. 
Solanum anguivi saponin is used in the 
management of diabetes and hypertension. It also has 
the potentials to induce antioxidant enzymes and 
decrease glucose levels in alloxanized rats112. 
Arjunolic acid, a triterpene saponin from 
Terminalia arjuna exhibits anti-diabetic activity by 
the inhibition of excessive reactive oxygen species’ 
formation. It also inhibits α-amylase and α-
glucosidase inhibitors113. Saponin isolated from 
Trigonella toenum-graecum significantly inhibited 
triglyceride accumulation, reduced the triglyceride 
content and mRNA expression levels of lipogenic 
genes and as a result, inhibits lipid accumulation in 
HepG2 cells of obese diabetic rats114. 
 
Alkaloids 
Alkaloids are secondary plant metabolites and are 
found also in bacteria, fungi and other animals. An 
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alkaloid is a true naturally occurring compound that 
contains basic nitrogen atoms. Some researchers 
regard alkaloids as a special case of amines115. 
Alkaloids are classified as true alkaloids e.g. 
nicotine, atropine, morphine; protoalkaloids e.g. 
mescaline, adrenaline, ephedrine; polyamine alkaloids 
e.g. putrescine, spermidine and spermine; pseudoalkaloids 
e.g. caffeine, theobromine, theophylline etc, peptide 
and cyclopeptide alkaloids115. 
Alkaloids have been implicated as the active 
principles in some anti-diabetic medicinal plants. 
Sharma et al.116 reported anti-diabetic potential of an 
alkaloid from Capparis deciduas in diabetic mice. 
The anti-diabetic mechanism of the alkaloid was 
reported as a significant improvement of GLUT 4, 
glucokinase activity and peroxisome PPARγ. Other 
mechanisms observed include reductions in total 
cholesterol, triglyceride, attenuation of glucose-6-
phosphatase activity and improvement in the hepatic 
glycogen content. Significant reductions in phosphoenol 
pyruvate carboxykinase and aldose reductase activities 
were also observed. 
Naturally occurring carbazole alkaloids isolated 
from Murraya koenigii have also been fingered as the 
anti-diabetic principles of that plant. Patel et al.117 
reported that koenidine increased insulin sensitivity, 
aided glucose uptake and GLUT 4 translocation in 
L6-GLUT4 myc myotubules. They further concluded 
that koenidine may be useful in managing insulin 
resistance and diabetes. 
In yet another study, Punitha et al.118 reported that 
benzyl tetra isoquinoline alkaloid-berberine exhibited 
anti-diabetic activity in streptozotocin-nicotinamide 
induced type 2 diabetic rats. Administration of the 
alkaloid in diabetic rats mitigated oxidative stress 
parameters, reduced elevated lipids, ameliorated 
glycosylation of haemoglobin and improved the 
antioxidant status while there were reductions in the 
activities of gluconeogenic enzymes. 
Alkaloids from Catharanthus roseus have also 
been reported by Tiong et al.119 as potent anti-diabetic 
and antioxidant compounds. The four alkaloids-
Vindoline I, Vindolidine II, Vindocine III and 
Vindolinine IV, isolated from dichloromethane extract 
of C.roseus induced relatively high glucose uptake in 
pancreatic beta TC6 or myoblast C2C12 cells with 
vindocine showing the highest activity. The compounds- 
Vindolidine II, Vindocine III and Vindolinine IV, 
inhibited protein tyrosinase phosphatase-1B (PTP-1B) 
while vindocine alleviated oxidative damage induced 
by hydrogen peroxide119.  
Moreover, alkaloids of Aerva lanata roots 
ameliorated diabetes in streptozotocin-nicotinamide 
induced type 2 diabetes in rats120. The authors 
reported that a partially purified alkaloid from the 
plant caused significant reductions in the serum 
glucose level 20 hrs post administration. The alkaloid 
was further identified as Canthin-6-one derivative120. 
Another alkaloid whose anti-diabetic potential has 
been reported is Fenugreek alkaloid. Abou El-Soud  
et al.121 submitted that administration of the alkaloid-
containing extract to streptozotocin-induced diabetic 
rats resulted in significant elevation of plasma insulin, 
decrease in serum lipids and lipid peroxide formation. 
 
Tannins 
Tannin is a polyphenolic biomolecule present in 
natural products such as berries, nuts, legumes, 
chocolate, spices and herbs122-124. Three major classes 
of tannins are distinguished viz: Hydrolyzable tannins 
e.g. gallic acid, Non-hydrolyzable or condensed tannins 
e.g. flavones and Phlorotannins e.g. phloroglucinol. 
Tannins have been reported as the bioactive anti-
diabetic principles of some medicinal plants. 
Hypoglycaemic Stachytarpheta indica has 6.4 % 
tannins as opposed to 2.5 % flavonoids125. Condensed 
tannins isolated from various food items such as 
cereals, legumes, oilseeds and vegetables have shown 
significant anti-diabetic and antioxidant properties. 
According to Kunyanga et al.126, condensed tannins 
extracted from α-amaranth grain, finger millet, field 
bean, sunflower seed, drumstick and amaranth leaves 
exhibited anti-diabetic effects mainly by inhibiting the 
activation of α-amylase and α-glucosidase activities. 
It has also been reported that tannic acid stimulates 
transportation of glucose and inhibition of differentiation 
in 3T3-L1 adipocytes127. This, according to them was 
achieved by phosphorylation of insulin receptor and 
translocation of glucose transporter 4 (GLUT 4). 
Tannic acid also inhibited the important genes for 
adipogenesis. 
 
Terpenes 
Terpenoid, andrographolide-lipoeic acid conjugate 
has demonstrated hypoglycemic potentials128. 
Benzofuran-2-carboxaldehyde is a hypoglycaemic 
diterpene isolated from Globba pendula129. Glucose 
lowering activities of diterpenoids of clerodane have 
also been reported130. Huang et al.131 demonstrated  
the anti-diabetic activities of stevioside and 
rebaudioside, diterpenes isolated from Stevia 
rebaudiana. Translocation of Glut 4 has been implicated 
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as the mechanism of its action. Hypoglycaemic and 
hypolipidaemic potentials of the diterpene, trans-
dehydrocrotonin (t-DCTN), from Croton cajucara has 
been demonstrated in alloxanized rats132. In the same 
vein, dehydroabietic acid has been found to suppress 
and increase pro-inflammatory (TNFα) and anti-
inflammatory (adiponectin) agents respectively133. 
Salvicin, Salvin and Salvifolin are bicyclic diterpenoids 
that have shown potentials as anti-diabetic agents134. 
Salacinol and Kotalanol are diterpenes isolated  
from Salaci oblonga and they have demonstrated  
anti-diabetic activities by inhibiting α-glucosidase 
activities135. Kotalegenin inhibits aldose reductase135. 
Salvipholin has demonstrated anti-diabetic activity 
through stability of insulin secretion136. 
In an earlier diterpenes- Icacenone, Icacinol, 
Humirianthenolide, 17-hydroxy-icacinol observed to be 
were responsible for the anti-diabetic activities 
exhibited by I. trichanta extract137. The extract was 
hypoglycaemic and hypolipidaemic in action. 
Potentiation of insulin action amongst other possible 
mechanisms was suggested as the mode of action of 
the extract. 
Triterpenes are a class of hydrocarbon compounds 
composed of three terpenes and consist of six 
isoprene units e.g. squalene. They are classified based 
on the number of rings they contain e.g. pentacyclic 
triterpenes (5 rings). Functionalized triterpenes are 
called triterpenoids. Other examples of triterpenes 
include polypodatetraene, malabaricane, lanostane, 
hopane, oleanane etc138,139,127. Triterpenoid saponins 
are triterpenes that belong to the saponin group of 
compounds. Plants produce them and they include 
eleutherosides, ginsenosides140. 
Some anti-diabetic plants have been reported to 
possess triterpenes as their bioactive principles. Tan et 
al.141 reported that triterpenoids isolated from bitter 
melon demonstrated anti-diabetic potentials by 
activation of the AMPK pathway. They further 
concluded that bitter melon (Momordica charantia) 
may be beneficial in the development of therapeutics 
for obesity and diabetes. 
Triterpenoid isolated from the root bark of 
Cussonia arborea also demonstrated potent anti-
diabetic properties in alloxan-induced diabetic rats142. 
 
Glycosides 
The anti-diabetic activity of Gymnema Sylvester was 
linked to the presence of glycoside contained therein143. 
Bioactive flavonoid glycosides isolated from 
Jatropha curcus has also been shown to possess anti-
diabetic activity in streptozotocin-induced diabetic 
rats144. The active principle acted by decreasing the 
serum α-amylase and lactate dehydrogenase activities. 
The extract also modulates oxidative stress parameters 
such as malondialdehyde. Cardiac glycoside isolated 
from the seed of Securigera securidaca (Fabaceae), a 
plant used in Iranian folk medicine as an anti-diabetic 
agent, mediate its hypoglycaemic activity by increasing 
insulin secretion145. Kaempferol is a glycoside-rich 
fraction obtained from unripe soybean leaves. Its anti-
diabetic activity is linked to its ability to reduce 
glycosylated haemoglobin. The liver fatty acid 
synthase was also decreased in the experiment 
following treatment with kaempferol146. Quercetin 
and quercetin 3-o-glycoside isolated from Vaccinium 
vitis crude berry extract showed hypoglycaemic 
activities by mediation through AMPK147. 
 
Others 
Other compounds with anti-diabetic activities such 
as polyunsaturated fatty acids and glycols have also 
been reported. In another study of ours entitled 
“Bioassay-guided isolation and structural elucidation 
of the anti-diabetic principle of methanol leaf extract 
of Newbouldia leavis (P. Beauv)”, we isolated 9-(4-
nonyl-phenyl)-non-8-enoic acid, a long chain 
unsaturated fatty acid from Newbouldia laevis as the 
anti-diabetic principle of the plant148. The 
polyunsaturated fatty acid exhibited hypoglycemic 
activities comparable to that achieved by the reference 
drug, glibenclamide, in the alloxan-induced diabetic 
rat. Pinitol, a sugar alcohol isolated from Sutherlandia 
frutescens leaves has shown great anti-diabetic 
activities. The anti-diabetic activities of pinitol were 
likened to that of insulin149. Asuzu and Nwaehujor150 
reported the anti-diabetic activities of D-3-O-
methylchiroinositol. Here we submitted not only the 
anti-diabetic but hypolipidaemic and antioxidant 
activities of D-3-O-methylchiroinositol isolated from 
the stem bark of Piliostigma thonningii. The structure 
of D-3-O-methylchiroinositolis given in Fig. 1. 
 
Discussion and Conclusion 
Diabetes mellitus is a metabolic and an endocrine 
disease affecting humans and animals with fatal 
consequences when left unmanaged. Management of 
this ailment can be in the form of modification of 
lifestyle, diet and use of anti-diabetic drugs such as 
oral hypoglycemics and insulin therapy. Synthetic 
anti-diabetic drugs are fraught with adverse side 
effects and are also expensive. 
ABA & ASUZU: A REVIEW OF BIOACTIVE COMPOUNDS OF MEDICINAL PLANTS 
 
 
91
Research into D. mellitus and its management in 
recent times has been geared towards isolation of 
efficacious active anti-diabetic agents of natural 
origin. A lot of studies have been carried out in 
various medicinal plants in this regard. Results have 
not only indicated that many medicinal plants possess 
anti-diabetic potentials but have demonstrated specific 
bioactive anti-diabetic principles and various 
mechanisms of actions of these agents. 
Bioactive anti-diabetic principles of plant origin are 
mainly phytochemicals which include but not limited 
to flavonoids, saponins, alkaloids, tannins, terpenes, 
and glycosides. These phytochemicals act in a number 
of diverse mechanisms to bring about their anti-
diabetic effects. Some of the mechanisms involved 
include increase in insulin secretion, decreases in 
hepatic glucose output, regulation of certain enzymes 
involved in carbohydrate metabolism such as α-
glucosidase inhibitors, modulation of certain 
regulation molecules such as PPARγ, hypolipidaemic 
activities, antioxidant effects, interference with  
the activities of some glycolytic enzymes such as 
phosphoenolpyruvate carboxykinase activities, 
amelioration of glycosylated haemoglobin, enhancement 
of the expression of glucose transporters and others. 
Flavonoids were observed to be the most popular 
anti-diabetic principle among the phytochemicals 
reviewed. These naturally occurring secondary plant 
metabolites (Phytochemicals) hold great potential for 
production of marketable, novel and effective anti-
diabetic drugs in near future. In general, bioactive 
anti-diabetic agents of plant origin constitute a group 
of natural products that have recently gained 
popularity in the health sector for management of 
various ailments such as diabetes mellitus. Satisfactory 
management of D. mellitus in future is pivotal on 
medicinal plants. 
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